When this barrier is disrupted, RPE cell activation occurs, leading to the proliferation, epithelial-mesenchymal transition (EMT), and secretion of extracellular matrix molecules, thus promoting vitreoretinal disorders, including proliferative vitreoretinopathy (PVR), age-related macular degeneration (AMD), and proliferative diabetic retinopathy (PDR) [1,2,3]
All compounds are supplied for research use only (RUO)
Thymosin beta-4 in a rat medial collateral ligament model
Our findings firstly demonstrated that MMA accumulation but not serum or dietary B12 was associated with increased cardiovascular mortality risk among patients with CHD
Most patients are diagnosed in the early weeks of treatment and have no symptoms or only mild signs